Patents
Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
12/2009
12/08/2009US7629340 N-(6-membered aromatic ring)-amido anti-viral compounds
12/08/2009CA2422342C Novel amide derivatives and medicinal use thereof
12/08/2009CA2404725C Extrusion die
12/08/2009CA2331969C Process for the manufacture of a sulfenimide
12/03/2009WO2009146013A1 Myosin light chain phosphatase inhibitors
12/03/2009WO2009145368A1 Improved preparing method of (s)-omeprazole from omeprazole racemate using optical resolution agent
12/03/2009WO2009109539A3 2-cyanobenzensulfonamide derivatives having pesticidal properties
12/03/2009US20090299073 Process for the Manufacture of Epoxybutanol Intermediates
12/03/2009US20090298899 EP receptor (for which the endogenous ligand is prostaglandin E2, PGE2); {3-[(4-Chloro-biphenyl-3-carbonyl)-amino]-phenyl}-acetic acid; glaucoma or ocular hypertension; dysmenorrhoea, preterm labour, immune disorders, inflammatory disorders
12/03/2009US20090298898 Pesticidally active ketone and oxime derivatives
12/03/2009US20090298896 Activating agent for peroxisome proliferator activated receptor delta
12/03/2009US20090298866 Indole Compounds
12/03/2009US20090298832 Trisubstituted thiazole compounds, preparations methods, pharmaceutical compositions and medicals uses thereof
12/03/2009US20090298177 Dat1
12/02/2009EP2128146A1 Heterocyclic compounds and heterocyclic polymers
12/02/2009EP2125761A1 Novel process for synthesis of pramipexole and its pharmaceutically acceptable salts
12/02/2009EP2125740A1 Fungicide n-(3-phenylpropyl)carboxamide derivatives
12/02/2009EP2125718A2 New substituted arylsulphonylglycines, the preparation thereof and the use thereof as pharmaceutical compositions
12/02/2009EP2125711A1 2 -substituted- 3 -phenylpropionic acid derivatives and their use in the treatment of inflammatory bowel disease
12/02/2009CN101591327A Benzene alkyl amides compound and usage thereof
12/02/2009CN101591306A Method for synthesizing rubber vulcanization accelerator CZ by oxygen oxidation method
12/02/2009CN101591305A Method for producing high-content pharmaceutical grade MBT
12/02/2009CN100564366C Derivatives of 1,3-diones having a herbicidal activity
12/01/2009US7626042 O-substituted hydroxyaryl derivatives
12/01/2009US7626037 Thiazolidin-4-one derivatives
12/01/2009US7626035 Optically active, heteroaromatic β-hydroxy esters and processes for their preparation from β-keto esters and processes for the preparation of these β-keto esters
12/01/2009US7626033 Compounds for the modulation of PPARγ activity
12/01/2009US7625948 Ester that inhibits MTP in intestines as antilipemic agents for side effect reduction
12/01/2009US7625944 carbamimidoyl benzylamide derivatives; preventing and treating the formation of thrombin during or after a PK dependent disease or condition after fibrinolysis treatment
12/01/2009US7625917 S-o-(phenylaminocarbonyl)phenyl-substituted, especially with a quaternary onium group; enhanced antiviral activity and better reactivity with zinc finger moieties, particularly, the zinc finger on HIV-1's NCp7 nucleocapsid protein
12/01/2009US7625914 2(S)-Ethoxy-3-{4-[2-(3-heptyl-1-methylureido)thiazol-4-yl]phenyl}propanoic acid; dermatology, and cardiovascular diseases, immune diseases, lipid metabolism diseases; veterinary medicine
12/01/2009US7625889 Substituted bis aryl and heteroaryl compounds as selective 5HT2A antagonists
12/01/2009CA2264556C Substituted n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides
11/2009
11/26/2009WO2009143041A1 Efficient production of heterologous proteins using mannosyl transferase inhibitors
11/26/2009WO2009142678A1 Protein labeling with cyanobenzothiazole conjugates
11/26/2009WO2009035542A3 Guanidine-containing compounds useful as muscarinic receptor antagonists
11/26/2009US20090291992 Androgen receptor-ablative agents
11/26/2009US20090291970 Substituted Aminoethers for the Treatment of Alzheimer's Disease
11/26/2009CA2724788A1 Hepatoprotectant acetaminophen mutual prodrugs
11/26/2009CA2721459A1 Efficient production of heterologous proteins using mannosyl transferase inhibitors
11/25/2009EP2123273A1 Therapeutic agent for urinary excretion disorder
11/25/2009EP2121583A1 Heteroaryl-substituted serine amides
11/25/2009EP2120580A2 Compositions and methods for the treatment of metabolic disorders
11/25/2009EP2120576A2 Aminoazoline and urea derivatives for combating animal pests
11/25/2009EP1638924B1 Pesticidally active ketone and oxime derivatives
11/25/2009EP1020454B1 Polymorphic modifications of 2-(3-cyano-4-isobutyloxyphenyl)-4-methyl-5-thiazole-carboxylic acid and processes for the preparation thereof
11/25/2009EP0931060B1 Substituted n- (aminoiminomethyl or aminomethyl)phenyl propyl amides
11/25/2009CN101585818A Preparation method for preparing intermediate body of Pramipexole dihydrochloride
11/25/2009CN101584691A Compounds effecting glucokinase
11/25/2009CN100562516C Beta-amyloid protein production/secretion inhibitors
11/25/2009CN100562513C Benzamide derivative or salt thereof
11/24/2009US7622593 Human protein tyrosine phosphatase inhibitors and methods of use
11/24/2009US7622472 Combination of Src kinase inhibitors and chemotherapeutic agents for the treatment of proliferative diseases
11/24/2009CA2418794C Calcium receptor antagonists
11/24/2009CA2408144C Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
11/24/2009CA2385882C Tyrosine derivatives
11/19/2009WO2009139811A2 Chemiluminescent methods and reagents for analyte detection
11/19/2009WO2009139076A1 Lipoprotein lipase-activating compositions comprising benzene derivates
11/19/2009US20090286841 Certain chemical entities, compositions, and methods
11/19/2009US20090286835 Novel compounds
11/19/2009US20090286776 Hexenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications thereof
11/19/2009US20090286261 Method for assaying compounds or agents for ability to displace potent ligands of hematopoietic prostaglandin d synthase
11/19/2009US20090285849 Thiosemicarbazones as anti-virals and immunopotentiators
11/19/2009CA2723455A1 Lipoprotein lipase-activating compositions comprising benzene derivates
11/18/2009EP2118084A1 Salts 668
11/18/2009EP2117526A2 Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme
11/18/2009EP2018367B1 Novel microbiocides
11/18/2009EP1421071B1 Substituted piperazine and diazepane derivaives as histamine h3 receptor modulators
11/18/2009CN101583600A Acetylene derivatives as stearoyl CoA desaturase inhibitors
11/18/2009CN101583593A Diaryl, dipyridinyl and aryl-pyridinyl derivatives and uses thereof
11/18/2009CN100560575C thiofide dibenzothiazyl disulfide preparation method
11/18/2009CN100560574C Thiazole oxime ether derivatives and preparation process and use thereof
11/17/2009US7619116 Intermediates for the synthesis of (R)-tamsulosin and of its pharmaceutically acceptable salts and process for their preparation
11/17/2009US7618990 4-[2-(4,4-Dimethyl-2-thioxo-1,3-oxazolidin-3-yl)-1,3-thiazol-4-yl]benzonitrile; progesterone receptor (PR); contraception, treating or preventing fibroids, endometriosis, dysfunctional bleeding, uterine leiomyomata, polycystic ovary syndrome, or hormone-dependent carcinomas, hormone replacement therapy
11/17/2009US7618989 Tricyclic oxazolidone derivatives useful as PR modulators
11/17/2009US7618981 Imidazopyridinyl-benzamide anti-cancer agents
11/17/2009US7618961 A sulfonylamino-tetrahydro(1,3)thiazolo(5,4-c)pyridinyl or benzothiazole derivatives, for treating diabetes, syndrome X, obesity, glaucoma, hyperlipidemia, hyperglycemia, hyperinsulinemia, osteoporosis, tuberculosis, dementia
11/17/2009CA2535511C Compounds having thrombopoietin receptor agonism
11/17/2009CA2510949C Polymorph of ritonavir
11/17/2009CA2463272C Piperazine derivatives with ccr1 receptor antagonist activity
11/17/2009CA2382296C Selective cox-2 inhibitory novel esters from indolealkanols and novel amides from indolealkylamines
11/17/2009CA2352494C Compositions and methods for the treatment of alzheimer's disease, central nervous system injury, and inflammatory diseases
11/12/2009WO2009137412A1 Therapeutic compounds
11/12/2009WO2009137411A1 Therapeutic compounds
11/12/2009WO2009137133A2 5-substituted-2-imino-thiazolidinone compounds and their use as inhibitors of bacterial infection
11/12/2009WO2009136663A1 Fused heterocyclic derivatives and use thereof
11/12/2009WO2009136576A1 Trisazo compound, ink composition, recording method and coloring material
11/12/2009WO2009135590A1 Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals
11/12/2009WO2009135526A1 Alpha-mercapto-amides
11/12/2009WO2009135407A1 A methoxyl acrylic ester fungicide, the preparation method and uses thereof
11/12/2009WO2009069132A3 Novel reverse transcriptase inhibitors
11/12/2009US20090281321 Exo- and diastereo- selective syntheses of himbacine analogs
11/12/2009US20090281154 Ophthalmic Compositions for Treating Ocular Hypertension
11/12/2009US20090281142 Thiazole derivative
11/12/2009US20090281138 Bis-(Sulfonylamino) Derivatives in Therapy 066
11/12/2009US20090281123 Novel thiazolo (4,5-d) pyrimidine compounds novel compounds
11/12/2009US20090281084 peroxisome proliferator-activated receptor agonists such as 3-{2-Chloro-4-[4-morpholin-4-ylmethyl-2-(4-trifluoromethyl-phenyl)-thiazol-5-ylmethoxy]-phenyl}-4H-[1,2,4]oxadiazol-5-one, suitable for the treatment and/or prevention of neurodegenerative diseases, metabolic and nervous system disorders
11/12/2009US20090280483 Methods for Screening Interleukin-6 (IL-6) Signal Transduction Inhibitors
11/12/2009CA2723550A1 Alpha-mercapto-amides
11/12/2009CA2723302A1 Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals
1 ... 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 ... 337